These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 29730322

  • 21. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties.
    Tsutsumi S, Iida M, Tada N, Kojima T, Ikeda Y, Moriwaki T, Higashi K, Moribe K, Yamamoto K.
    Int J Pharm; 2011 Dec 15; 421(2):230-6. PubMed ID: 21983091
    [Abstract] [Full Text] [Related]

  • 22. Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.
    Sarkar A, Rohani S.
    J Pharm Biomed Anal; 2015 Jun 10; 110():93-9. PubMed ID: 25818704
    [Abstract] [Full Text] [Related]

  • 23. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D, Yin S, Pan D, Crull G, Timmins P, Vig B.
    Mol Pharm; 2017 Feb 06; 14(2):377-385. PubMed ID: 28068097
    [Abstract] [Full Text] [Related]

  • 24. Crystal forms of naproxen.
    Song JS, Sohn YT.
    Arch Pharm Res; 2011 Jan 06; 34(1):87-90. PubMed ID: 21468919
    [Abstract] [Full Text] [Related]

  • 25. Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.
    Onoue S, Inoue R, Taniguchi C, Kawabata Y, Yamashita K, Wada K, Yamauchi Y, Yamada S.
    Int J Pharm; 2012 Apr 15; 426(1-2):61-66. PubMed ID: 22266536
    [Abstract] [Full Text] [Related]

  • 26. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M, Liebenberg W, Aucamp M.
    AAPS PharmSciTech; 2015 Oct 15; 16(5):1190-202. PubMed ID: 25732372
    [Abstract] [Full Text] [Related]

  • 27. Pharmaceutical Salts of Carvedilol: Polymorphism and Physicochemical Properties.
    Hiendrawan S, Widjojokusumo E, Veriansyah B, Tjandrawinata RR.
    AAPS PharmSciTech; 2017 May 15; 18(4):1417-1425. PubMed ID: 27600325
    [Abstract] [Full Text] [Related]

  • 28. Crystal structure and physicochemical properties of crystalline form of 2'-O-{3-[(7-chloro-4-quinolinyl)amino]propyl}-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin A.
    Filić D, Starčević K, Pešić D, Jurmanović S, Meenan E, Spezzaferri A, Đilović I, Prugovečki B.
    J Pharm Sci; 2011 Jul 15; 100(7):2586-98. PubMed ID: 21394721
    [Abstract] [Full Text] [Related]

  • 29. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA, Ji Q, Joshi YM, Serajuddin AT.
    Int J Pharm; 2007 Jun 07; 337(1-2):210-8. PubMed ID: 17296277
    [Abstract] [Full Text] [Related]

  • 30. Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt.
    Paluch KJ, Tajber L, Elcoate CJ, Corrigan OI, Lawrence SE, Healy AM.
    J Pharm Sci; 2011 Aug 07; 100(8):3268-3283. PubMed ID: 21472730
    [Abstract] [Full Text] [Related]

  • 31. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A.
    Pharm Res; 2006 Aug 07; 23(8):1888-97. PubMed ID: 16832611
    [Abstract] [Full Text] [Related]

  • 32. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
    Otsuka M, Kato F, Matsuda Y.
    AAPS PharmSciTech; 2002 Aug 07; 3(4):E30. PubMed ID: 12916924
    [Abstract] [Full Text] [Related]

  • 33. Improving the Solubility, Stability, and Bioavailability of Albendazole through Synthetic Salts.
    Yan H, Zhong X, Liu Y.
    Molecules; 2024 Jul 29; 29(15):. PubMed ID: 39124976
    [Abstract] [Full Text] [Related]

  • 34. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 29; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

  • 35. New solid modifications of nateglinide.
    Bruni G, Berbenni V, Milanese C, Girella A, Cardini A, Lanfranconi S, Marini A.
    J Pharm Biomed Anal; 2010 Apr 06; 51(5):1054-9. PubMed ID: 20022441
    [Abstract] [Full Text] [Related]

  • 36. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A, Cavallari C, Ospitali F.
    Eur J Pharm Biopharm; 2008 Sep 06; 70(1):409-20. PubMed ID: 18621516
    [Abstract] [Full Text] [Related]

  • 37. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
    Skrdla PJ, Zhang D.
    J Pharm Biomed Anal; 2014 Mar 06; 90():186-91. PubMed ID: 24378612
    [Abstract] [Full Text] [Related]

  • 38. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG.
    Int J Pharm; 2010 Aug 16; 395(1-2):161-6. PubMed ID: 20580799
    [Abstract] [Full Text] [Related]

  • 39. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P, Lee PI.
    Eur J Pharm Biopharm; 2007 Mar 16; 65(3):320-8. PubMed ID: 17182231
    [Abstract] [Full Text] [Related]

  • 40. Role of moisture on the physical stability of polymorphic olanzapine.
    Paisana MC, Wahl MA, Pinto JF.
    Int J Pharm; 2016 Jul 25; 509(1-2):135-148. PubMed ID: 27234701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.